DLGAP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.655600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.512800E-01
Normal-vs-Stage2
4.346200E-01
Normal-vs-Stage3
3.398800E-01
Normal-vs-Stage4
5.406800E-01
Stage1-vs-Stage2
5.470000E-01
Stage1-vs-Stage3
5.927800E-01
Stage1-vs-Stage4
3.920400E-01
Stage2-vs-Stage3
2.444200E-01
Stage2-vs-Stage4
9.116200E-01
Stage3-vs-Stage4
4.016000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.512200E-01
Normal-vs-AfricanAmerican
4.405800E-01
Normal-vs-Asian
8.305000E-01
Caucasian-vs-AfricanAmerican
9.818200E-01
Caucasian-vs-Asian
3.447400E-01
AfricanAmerican-vs-Asian
5.251000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.830400E-01
Normal-vs-Female
4.584000E-01
Male-vs-Female
8.980200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.702400E-01
Normal-vs-Age(41-60Yrs)
7.256000E-01
Normal-vs-Age(61-80Yrs)
3.927000E-01
Normal-vs-Age(81-100Yrs)
2.954200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.137400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.105000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.498800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.338200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.479700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.315800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.127600E-01
Normal-vs-Daily Drinker
4.761400E-01
Normal-vs-Weekly Drinker
8.645400E-01
Normal-vs-Occasional Drinker
7.304400E-01
Normal-vs-Social Drinker
9.507000E-01
Non Drinker-vs-Daily Drinker
3.754200E-01
Non Drinker-vs-Weekly Drinker
9.432200E-02
Non Drinker-vs-Occasional Drinker
6.563600E-02
Non Drinker-vs-Social Drinker
1.031430E-01
Daily Drinker-vs-Weekly Drinker
3.979200E-01
Daily Drinker-vs-Occasional Drinker
3.975800E-01
Daily Drinker-vs-Social Drinker
2.313000E-01
Weekly Drinker-vs-Occasional Drinker
8.661800E-01
Weekly Drinker-vs-Social Drinker
7.138200E-01
Occasional Drinker-vs-Social Drinker
5.770400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.483800E-01
Normal-vs-Grade 2
9.281000E-01
Normal-vs-Grade 3
9.803800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.216000E-01
Grade 1-vs-Grade 3
5.939600E-01
Grade 1-vs-Grade 4
9.483800E-01
Grade 2-vs-Grade 3
1.706590E-01
Grade 2-vs-Grade 4
9.281000E-01
Grade 3-vs-Grade 4
9.803800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.333000E-01
Normal-vs-NonDiabetic
6.519800E-01
Diabetic-vs-NonDiabetic
7.886000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.923600E-01
Normal-vs-NoPancreatitis
4.883200E-01
Pancreatitis-vs-NoPancreatitis
2.504000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.032000E-01
Normal-vs-N1
4.558200E-01
N0-vs-N1
8.811200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.307200E-01
Normal-vs-TP53-NonMutant
3.158800E-01
TP53-Mutant-vs-TP53-NonMutant
1.232610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
